Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients

Journal of Neuroimmunology

Volumn 197, Issue 2, 2008, Pages 140-146

  Ruggieri, Maddalena ^a   Pica, Carmela ^a   Lia, Anna ^a   Zimatore, Giovanni B ^a   Modesto, Mattea ^b   Di Liddo, Emilia ^a   Specchio, Luigi M ^b   Livrea, Paolo ^a   Trojano, Maria ^a   Avolio, Carlo ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Dendritic cells; Glatiramer Acetate; Minocycline; Multiple Sclerosis

Indexed keywords

BIOLOGICAL MARKER; CD83 ANTIGEN; GLATIRAMER; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; MINOCYCLINE; T6 ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIGENS, CD; CELLS, CULTURED; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MINOCYCLINE; MULTIPLE SCLEROSIS; PEPTIDES;

EID: 46649096996     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.04.032     Document Type: Article

References (21)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Bergh F.T., Dayyani F., and Ziegler-Heitbrock L. Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells. An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta. J. Neuroimmunol. 146 (2004) 176-188
3. Blanco P., Palucka A.K., Gill M., Pascual V., and Banchereau J. Induction of dendritic cell differentiation by IFNbeta in systemic lupus erythematosus. Science 294 (2001) 1540-1543
4. Brundula V., Rewcastle N.B., Metz L.M., Bernard C.C., and Yong V.W. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125 (2002) 1297-1308
5. Costello F., Stuve O., Weber M.S., Zamvil S.S., and Frohman E. Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice. Curr. Opin. Neurol. 20 (2007) 281-285
6. Dhib-Jalbut S. Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis. Neurology 58 (2002) S3-S9
7. ElBehi M.E., Dubucquoi S., Lefranc D., Zephir H., De Seze J., Vermersch P., and Prin L. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Lett. 96 (2005) 11-26
8. Giuliani F., Metz L.M., Wilson T., Fan Y., Bar-Or A., and Yong V.W. Additive effect of the combination of glatiramer acetate and minocycline in a model of MS. J. Neuroimmunol. 158 (2005) 213-221
9. Giuliani F., Fu S.A., Metz L.M., and Yong V.W. Effective combination of minocycline and interferon-beta in a model of multiple sclerosis. J. Neuroimmunol. 165 (2005) 83-91
10. Huang Y.M., Stoyanova N., Jin Y.P., Teleshova N., Hussien Y., Xiao B.G., Fredrikson S., and Link H. Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFNbeta and IL-10. Clin. Exp. Immunol. 124 (2001) 306-314
11. Hussien Y., Sanna A., Soderstrom M., Link H., and Yu-Min Huang Y.M. Glatiramer acetate and IFN-b act on dendritic cells in multiple sclerosis. J. Neuroimmunol. 121 (2001) 102-110
12. Jonuleit H., Edgar Schmitt E., Kerstin Steinbrink K., Alexander H., and Enk A.H. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22 (2001) 394-400
13. Karni A., Abraham M., Monsonego A., Cai G., Freeman G.J., Hafler D., Khoury S.J., and Weiner H.L. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol. 177 (2006) 4196-4202
14. Maier K., Merkler D., Gerber J., Taheri N., Kuhnert A.V., Williams S.K., Neusch C., Bahr M., and Diem R. Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation. Neurobiol. Dis. 25 (2007) 514-525
15. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
16. Popovic N., Schubart A., Goetz B.D., Zhang S.C., Linington C., and Duncan I.D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann. Neurol. 51 (2002) 215-223
17. Sanna A., Fois M.L., Arru G., Huang Y.M., Link H., Pugliatti M., Rosati G., and Sotgiu S. Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis. Clin. Exp. Immunol. 143 (2006) 357-362
18. Vieira P.L., Heystek H.C., Wormmeester J., Wierenga E.A., and Kapsenberg M.L. Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J. Immunol. 170 (2003) 4483-4488
19. Weber M.S., Prod'homme T., Youssef S., Dunn S.E., Rundle C.D., Lee L., Patarroyo J.C., Stuve O., Sobel R.A., Steinman L., and Zamvil S.S. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 3 (2007) 935-943
20. Yong V.W., Wells J., Giuliani F., Casha S., Power C., and Metz L.M. The promise of minocycline in neurology. Lancet Neurol. 3 (2004) 744-751
21. Zabad R.K., Metz L.M., Todoruk T.R., Zhang Y., Mitchell J.R., Yeung M., Patry D.G., Bell R.B., and Yong V.W. The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Mult. Scler. 13 (2007) 517-526